Skip to main content
SpringerLink
Log in

“Bridging” Therapy with Low Molecular Weight Heparin in Pregnant Patients and Patients with Mechanical Prosthetic Heart Valves

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

A substantial body of published, peer-reviewed, trial and cohort study—based evidence, institutional data sets and expert clinical experience/opinion supports the safe and effective use of enoxaparin for anticoagulation management of non-pregnant patients with prosthetic mechanical heart valves. A comparable body of data and trial results exists, also supported by a significant and authoritative base of expert opinion, for enoxaparin-based VTE prevention and treatment of at-risk pregnant patients who do not have mechanical heart valves. In pregnant women with prosthetic mechanical heart valves, no recommendations on the use of LMWHs can be made until the availability of more data (Lovenox Injection (package insert). Available at www.aventis-us.com/PIs/lovenox. Accessed July 30, 2003. Aventis Pharmaceuticals 2003).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lovenox Injection (package insert). Aventis Pharmaceuticals, 2002.

  2. Lovenox Injection (package insert). Available at www. aventis-us.com/PIs/lovenox. Accessed July 30, 2003. Aventis Pharmaceuticals, 2003.

  3. Data on File. Aventis Pharmaceuticals, 2002.

  4. Laurent P, Dussarat GV, Bonal J, et al. Low molecular weight heparins: A guide to their optimum use in pregnancy. Drugs 2002;62:463-477.

    Google Scholar 

  5. Stein PD, Alpert JS, Bussey HI, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220s-227s.

    Google Scholar 

  6. Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000;1010:1083-1086.

    Google Scholar 

  7. Johnson J, Turpie AGG. Temporary discontinuation of oral anticoagulants: Role of low molecular weight heparin (abstract). Thromb Haemost 2001; Abstract P2323.

  8. Berdague P, Boneu B, Soula P, et al. Usefulness of lowmolecular weight heparins during post-operative period in mitral mechanical valve replacement: Clinical ischaemic and haemorrhagic complications in 110 cases [abstract]. Eur Hear J 1999;19(Abstrt. Suppl):534. Abstract P2965.

    Google Scholar 

  9. Ferreira IJ, Dos L, Tornos MP, et al. Is low-molecular weight heparin a safe alternative to unfractionated heparin in patients with mechanical heart valves who must interrupt antithrombotic therapy. Eur Heart J 2000; 21 (Abstract Suppl 310). Abstract P1666.

  10. Ferreira I, Dos L, Tornos P, et al. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003;89:527-530.

    Google Scholar 

  11. Ellison J, Walker ID, Greer IA. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. Br J Obstet Gynecol 2000;107:1116-1121.

    Google Scholar 

  12. Dulitzki M, Pauzner R, Langevitz P, et al. Low molecular weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies. Obstet Gynecol 1996;87:380-383.

    Google Scholar 

  13. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecularweight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997;176:1062-1068.

    Google Scholar 

  14. Bonnar J, Norris LA, Greene R. Low molecular weight heparin for thromboprophylaxis during caesarean section. Thromb Res 1999;96:317-322.

    Google Scholar 

  15. Borel-Derlon A, Borg JY, Boudignat O. Assessment of a low molecular weight heparin (enoxaparin) safety during pregnancy: A retrospective study of 624 pregnancies (Abstract). International Society of Thrombosis and Hemostasis 1999:1550.

  16. Position statement on LMWH posted on http://www.smfm.org/. Accessed July 30, 2003.

  17. Casele H, Laifer A, Woelkers DA, et al. Changes in the pharmacokinetics of the low molecular weight heparin enoxaparin sodium during pregnancy.AmJ Obstet Gynecol 1999;181:1113-1117.

    Google Scholar 

  18. Ellison J, Thomson AJ, Walker ID, et al. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. Br J Obstet Gynecol 2001;108:757-759.

    Google Scholar 

  19. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122s-131s.

    Google Scholar 

  20. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Bog 2000;107:245-253.

    Google Scholar 

  21. Meschengieser SS, Fondevila CG. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23-26.

    Google Scholar 

  22. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. Journal of the American College of Cardiology 1996;27:1698-1703.

    Google Scholar 

  23. Watson WJ, Freeman J, O'Brien C, Benson M. Embolic stroke in a pregnant patient with amechanical heart valve on optimal heparin therapy. American Journal of Perinatology 1996;13:371-372.

    Google Scholar 

  24. Salazar E, Zajarias A, Guiterrez N. The problem of cardiac valve prostheses, anticoagulants and pregnancy. Circulation 1997;70(Suppl 1):169-177.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Campbell University School of Pharmacy, Greensboro, NC, 27401-1020, USA

    James B. Groce III (Associate Professor of Pharmacy)

Authors
  1. James B. Groce III
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Groce III, J.B. “Bridging” Therapy with Low Molecular Weight Heparin in Pregnant Patients and Patients with Mechanical Prosthetic Heart Valves. J Thromb Thrombolysis 16, 79–82 (2003). https://doi.org/10.1023/B:THRO.0000014599.17795.39

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:THRO.0000014599.17795.39

Search

Navigation